文献速递关节外科创伤骨科

患者危险因素不影响全踝关节置换术后90天再入院和急诊就诊:对综合关节置换(CJR)捆绑支付计划的启示

Patient Risk Factors Do Not Impact 90-Day Readmission and Emergency Department Visitation After Total Ankle Arthroplasty: Implications for the Comprehensive Care for Joint Replacement (CJR) Bundled Payment Plan.
PubMed 文献 · J Bone Joint Surg Am · 2018-01-01

本研究回顾性分析了美国东南部单中心1024例全踝关节置换术患者,旨在检验患者合并症是否与术后90天再入院、急诊就诊及伤口愈合专科会诊相关。结果显示5.2%患者再入院,3.5%患者急诊就诊,多变量模型中无任何合并症与90天再入院、急诊就诊或伤口并发症显著相关。作者认为全踝关节置换术与全髋/全膝关节置换术可能存在显著差异,外科医生应质疑将全踝关节置换术纳入CJR捆绑支付模式的合理性。

要点

  • 多变量模型未发现任何患者合并症与90天再入院、急诊就诊或伤口并发症显著相关。
  • 90天再入院率为5.2%(53/1024),急诊就诊但未入院率为3.5%(36/1024)。
  • 再入院或急诊就诊最常见原因为伤口并发症,其次为深静脉血栓和肺栓塞评估。

核心结论

  • 患者合并症与全踝关节置换术后90天再入院或急诊就诊不相关。
  • 再入院主要由伤口不良事件以及深静脉血栓和肺栓塞评估所致。
  • 这些数据提示全踝关节置换术与全髋或全膝关节置换术之间可能存在显著差异,使外科医生质疑将全踝关节置换术纳入CJR捆绑支付模式。

研究设计与样本

  • 回顾性研究,在美国东南部单一学术中心进行。
  • 2007年6月至2016年12月期间所有接受全踝关节置换术的患者(n=1365)均符合入选条件,其中1037例同意参与并接受手术,1024例(98.7%)完成研究。
  • 记录全踝关节置换术前基于Elixhauser和Charlson-Deyo合并症指数的医疗合并症。
  • 采用单变量和多变量显著性检验分析患者及手术特征与结局的关系。
  • 证据等级:预后Level IV。

主要发现

  • 1024例患者中496例(48.4%)为女性,964例(94.1%)为白人/高加索人,平均年龄(及标准差)为63±10.5岁。
  • 高血压、肥胖、实体瘤、抑郁、风湿性疾病、心律失常、甲状腺功能减退、糖尿病和慢性肺病的患病率>10%。
  • 1024例中53例(5.2%)因任何原因再入院。
  • 1024例中36例(3.5%)返回急诊但未收入院。
  • 多变量模型中无任何患者合并症与90天再入院、急诊就诊或伤口并发症显著相关。

关键数值与推荐

  • 90天再入院率:5.2%(53/1024)。
  • 90天急诊就诊但未入院率:3.5%(36/1024)。
  • 平均年龄:63±10.5岁(n=1024)。
  • 女性比例:48.4%(496/1024)。
  • 白人/高加索人比例:94.1%(964/1024)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Comprehensive Care for Joint Replacement (CJR) model provides bundled payments for in-hospital care and care within 90 days following discharge for Medicare beneficiaries undergoing lower-extremity joint replacement involving the hip, knee, or ankle (total hip arthroplasty, total knee arthroplasty, or total ankle arthroplasty [TAA]). The study hypothesis was that patient comorbidities are associated with readmissions, emergency department (ED) utilization, and subspecialist wound-healing consultation, which are examples of costly contributors to postoperative health-care spending. METHODS: The medical records for 1,024 patients undergoing TAAs between June 2007 and December 2016 at a single academic center in the southeastern United States were reviewed for the outcomes of readmissions, ED visitations, and subspecialist wound-healing consultation within the 90-day post-discharge period. All patients undergoing TAA (n = 1,365) were eligible. Of the 1,037 patients who consented to participation in the study and underwent TAA, 1,024 (98.7%) completed the study. Medical comorbidities according to the Elixhauser and Charlson-Deyo comorbidity indices that were present prior to TAA were recorded. Univariate and multivariable tests of significance were used to relate patient and operative characteristics to outcomes. RESULTS: Four hundred and ninety-six (48.4%) of the 1,024 patients were female, and 964 (94.1%) were white/Caucasian, with an average age (and standard deviation) of 63 ± 10.5 years. Hypertension, obesity, solid tumor, depression, rheumatic disease, cardiac arrhythmia, hypothyroidism, diabetes mellitus, and chronic pulmonary disease had a prevalence of >10%. Fifty-three (5.2%) of the 1,024 patients were readmitted for any cause. Thirty-six (3.5%) of the 1,024 returned to the ED but were not admitted to the hospital. Readmission or ED visitation was most commonly for a wound complication, followed by deep venous thrombosis (DVT) and pulmonary embolism (PE) evaluation, while urgent medical evaluations composed the majority of non-TAA-related ED visitations. No patient comorbidities were significantly associated with 90-day readmission, ED visitation, or wound complications in multivariable models. CONCLUSIONS: Patient comorbidities were not associated with 90-day hospital readmissions or ED visitation for patients undergoing TAA. Readmissions were dominated by evaluation of wound compromise as well as DVT and PE. These data suggest that there may be considerable differences between TAA and total hip arthroplasty or total knee arthroplasty that cause surgeons to question the inclusion of TAA in CJR bundled payment models. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Cunningham D, Karas V, DeOrio J, et al. Patient Risk Factors Do Not Impact 90-Day Readmission and Emergency Department Visitation After Total Ankle Arthroplasty: Implications for the Comprehensive Care for Joint Replacement (CJR) Bundled Payment Plan. J Bone Joint Surg Am. 2018. PMID: 30063591. doi:10.2106/JBJS.17.01149

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。